Asia-focused venture capital firm Vickers Venture Partners said it has received US$200 million in commitments for its US$500 million fund – the sixth one managed by the firm.
Vickers Venture Partners chairman Finian Tan / Photo credit: Vickers Venture Partners
“With Fund VI, we are extremely excited to continue investing globally in deep, disruptive technologies that are creating solutions that are more inclusive and sustainable for societies around the world,” Vickers chairman Finian Tan said.
Founded in 2005, the VC firm focuses on early-stage investments in Asia and beyond, covering life sciences, technology, media, telecommunications, as well as consumer and financial services.
One of its most recent investments include UK-based biotech company Emergex, which raised US$11 million in a series A funding round earlier this year. The startup is trying to develop safe and effective vaccinations against Covid-19 and other prevalent infectious diseases.
Vickers has also backed Singaporean fintech startup MatchMove, which is currently valued at about US$300 million. Other portfolio companies include Samumed, Snapcart, M-Daq, and the Asian Food Channel, among others.
In October 2017, the company raised US$230 million for its Fund V to invest in startups globally, with a focus on deep-tech and impact investments in emerging markets.
“Fund IV and V have a projected return of 10 times, and we expect Fund VI to follow in the footsteps,” Tan told Reuters.
Vickers is headquartered in Singapore, with offices in Shanghai, Hong Kong, New York, San Diego, Silicon Valley, and London.
Editing by Charmaine de Lazo
(And yes, we’re serious about ethics and transparency. More information here.)
Stay updated on the go with our mobile app.
Get latest insights with smoother, more personalized experience through TIA mobile app.
